miRNA-214 to predict progression and survival in ALS
Plasma miRNA-214 could serve as a novel biomarker for predicting the progression and prognosis of ALS.
Authors
- Jinseok Park (ORCID: https://orcid.org/0000-0001-6581-5831)
- Minyeop Nahm (ORCID: https://orcid.org/0000-0003-2195-4084)
- Min‐Young Noh (ORCID: https://orcid.org/0000-0002-2746-0686)
- Hee Kyung Jin (ORCID: https://orcid.org/0000-0001-6403-008X)
- Bugyeong Son
- Ki‐Wook Oh (ORCID: https://orcid.org/0000-0001-6011-629X)
- Jae‐sung Bae (ORCID: https://orcid.org/0000-0002-8270-0072)
- Seung Hyun Kim (ORCID: https://orcid.org/0000-0001-9644-9598)
- Min‐Soo Kwon (ORCID: https://orcid.org/0000-0002-2837-881X)
Institutions
- Kyungpook National University (KR)
- Gyeonggi Research Institute (KR)
- CHA University (KR)
- Hanyang University Medical Center (KR)
- Korea Brain Research Institute (KR)
- Hanyang University (KR)
Publication Details
- Journal
- Journal of Neurology Neurosurgery & Psychiatry
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1136/jnnp-2024-335177
- Citations
- 6
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 8.34
Funders
- Hanyang University
- Ministry of Science and ICT, South Korea
- College of Medicine, Hanyang University